Technology Offerings

Novel Rhodium and Iridium Compounds Target Cancer Cells

These novel rhodium complexes were tested on breast cancer (MCF-7) and colon cancer (HT-29) cell lines and exhibit cytotoxicities of up to 100 times higher than Cisplatin.

Further Information: PDF

rubitec – Gesellschaft für Innovation und Technologie der Ruhr-Universität Bochum mbH
Phone: +49 (0)234/32-11969

Contact
Dietmar Tappe

Comments (0)

Write a comment